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Introduction
Multipotent stem cells may be beneficial in tissue engineering 
applications for reconstructive surgery, particularly for soft tissue 
enhancement and around implants for better integration [1,2] and 
potentially for burn patients [3-6].
Until recently, the predominant source of stem cells considered 
for clinical applications was bone marrow-derived mesenchymal 
stem cells (BM-MSCs). More recent studies using fresh stem cells 
derived from white adipose tissue, termed adipose-derived stem cells 
(ASCs) [7], have confirmed them as multipotent mesenchymal stem 
cells [8-11]. Advantages are high availability and easy accessibility 
from direct excision or from fresh lipoaspirate [12]. It was shown 
that their therapeutic potential is equal or even superior compared 
to BM-MSCs because of their higher number and viability upon 
transplantation [8,13].
In severely burned patients, it is now accepted that co-culture 
of both fibroblasts (dermal) and keratinocytes (epidermal) provides 
a better clinical outcome for burn applications [14]. With such 
patients, there is also a lack of soft tissue and adipose tissue injection 
has been proposed to help in scar tissue remodelling [3]. Therefore, 
with standardized methods for ASC culture using small quantities 
of tissue (that could be taken during initial debridement and biopsy 
for keratinocyte culture), these patient cells could be easily integrated 
into the co-cultured treatment for burns and perhaps provide a better 
overall treatment for skin and soft tissue reconstruction.
Isolation methods from lipoaspirate digested using collagenase, 
filtered and finally centrifuged have been used in research [2]. Recent 
techniques have shown that less aggressive enzymatic treatment 
using trypsin could be employed for better cellular stability but had 
lower overall cell yields. Reports have demonstrated that although 
mechanically isolated ASCs (mincing) revealed lower cell numbers, 
the viability was higher [15-17]. In addition, Zeng et al. [18] have 
shown isolation of ASCs without collagenase or trypsin although 
they treated the tissue for 3 consecutive days with 100% fetal bovine 
(FBS) serum to “digest” the tissue and allow cells to emerge from the 
tissue mass. Although many protocols have been tested and allowed 
to improve stability by decreasing enzymatic treatment, ASCs remain 
a cell population that loses growth potential already beginning 
in passage 4 (similar to that seen in BM-MSCs) and has difficult 
recovery following freezing [19]. Even if ASCs have been proposed 
as the best stem cell source in terms of quantity, large amounts of 
tissue are generally not available from burn patients, so we optimized 
a standard method for rapid ASC isolation revising latest results of 
protocols without enzymatic digestion and using only very small 
quantities of tissue. Important culture parameters for clinical use 
were controlled, including population growth and stability and 
differentiation potential. The growth of ASCs co-cultured with 
progenitor skin fibroblasts was evaluated for potential increase in cell 
number, quality, and overall robustness to better prepare cells for in 
vivo environments.
Abstract
Co-culture techniques associating both dermal fibroblasts and 
epidermal keratinocytes have shown to have better clinical outcome 
than keratinocyte culture alone for the treatment of severe burns. 
Since fat grafting has been shown to improve scar remodelling, new 
techniques such as cell-therapy-assisted surgical reconstruction 
with isolated and expanded autologous adipose-derived stem cells 
(ASCs) would be of benefit to increase graft acceptation. Therefore, 
integrating ASCs into standardized procedures for cultured skin 
grafting could be of benefit for the patient if cell quality and quantity 
could be maintained. The purpose of this study was to evaluate 
ASC processing from adult tissue with simple isolation (without 
enzymatic steps), expansion (low density of 325-3,000 cells/cm2) 
and storage conditions to assure methods to enhance the cellular 
resistance when transferred back to the patient. Co-culture with 
cell-banked skin progenitor cells (FE002-SK2) showed an increase 
of 40-50% ASCs yield at high passages alongside with a better 
preservation of morphology, proper adipogenic and osteogenic 
differentiation and efficient biocompatibility with 3D collagen 
scaffolds. ASCs can be considered as a valuable additional cell 
source to be delivered in biological bandages to the patient in a 
need of tissue reconstruction such as burn patients.
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Lipofilling, Burn treatment, Biological bandages
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High expectations that these cells may help solve some of the 
reconstruction problems faced in clinics could be met if the cell source 
can be shown to be stable, reliable and routinely isolated, cultured 
and stocked under standardized systems allowing for safe clinical use.
Experimental Methods
Tissue processing, isolation and cell bank preparation
Adipose tissue from healthy patients (n=15, between 27-61 yr 
- average age and standard deviation of 46.1 ± 2.0 years and mean 
BMI of 25.4 ± 0.8kg/m2) (Table 1) undergoing various elective 
reconstructive surgeries were obtained either by direct excision 
or manual aspiration (Protocol included in the Department of 
Musculoskeletal Biobank Regulation: 12/2012 “Conservation of 
Biological human material for research”). They were given a code 
(Table 1) and placed in 50ml sterile polypropylene tubes containing 
transport solution of phosphate buffered saline (PBS) (NaCl 6.8g/l, 
Na2HPO4 1.5g/l, KH2PO4 0.4g/l) and 1% penicillin-streptomycin 
(P/S). Samples were processed within 12 hours and were rinsed twice 
with 5% P/S in PBS for 10 min until connective tissue and blood were 
released. Tissue (~10g) was then minced into small pieces (diameter: 
<5mm) and the washing step was again repeated in 2% P/S in PBS. 
Approximately 1g of tissue was then directly seeded onto 10cm petri 
dishes prepared with scalpel incisions to attach tissue fragments at 
<20% density of the surface (Figure 1). Initial experiments using 
three patient tissues were accomplished to determine the influence 
of cell culture media, based on population doubling-time and 
morphological analysis. Culture media assessed were as follows: A. 
Dulbecco’s modified Eagle medium (DMEM, Gibco) / FBS (Sigma) 
/ l-glutamine (l-glut, Gibco) (89:10:1); B. DMEM / Ham-F12 - 
GlutaMAX®-I (Gibco) / FBS (45:45:10); C. DMEM / Iscove’s Modified 
Dulbecco’s Medium (IMDM, Gibco) - GlutaMAX®-I / FBS (45:45:10); 
D. DMEM / Minimum essential medium alpha (α-MEM, Gibco) / 
FBS / l-glut (59:30:10:1). Samples were cultured in an incubator 
(37°C, 95% humidity, 5% CO2) and culture media was renewed twice 
a week. Cells were then passed when reaching 80-90% confluency 
by removing cells from culture plates with 2ml of TrypLE® Express 
(TrypLE: Gibco) for 10 min. Cells were then reseeded into 75cm2 
flasks for further expansion. Cell banks were established for each 
patient up to passages 3-4, by freezing a minimum of 20 vials of cells 
at 1 million cells in 1ml freezing media [50% culture media, 40% FBS 
and 10% dimethyl sulphoxide (DMSO)] and cryopreserved at -80°C 
until later use. Cells were cryopreserved for a minimum of 2 weeks to 
measure overall viability. They were then seeded into 6-well culture 
plates at 1,500 cells/cm2 density to assess for potential adverse impact 
on cell growth rate and recovery following freezing (hemocytometer 
total viable cell counts with trypan blue exclusion, n=3). Cells 
that were cryopreserved were compared to cells that had not been 
cryopreserved in the same passage. Morphology of cells was captured 
in images at 8 days of culture and counting and doubling times were 
assessed at 14 days of culture.
Mechanical versus enzymatic isolation of adipose-derived 
stem cells
ASCs from two patients were isolated and harvested as described 
above, and the cells from two other patients were isolated with 
collagenase for either 30 min or 120 min according to the protocol 
from Buschmann et al. [20]. All four cell lines established were used 
at the same passage (P2) for experimentation. Cells from each cell 
line were seeded in triplicate into 96-well culture plates at 3,000 cells/
cm2 in order to assess differences between growths of collagenase- 
and mechanically-isolated cells up to 19 days. Growth rates were 
assessed following a metabolic assay based on Cell Titer (Promega) 
and metabolite absorbance (Tecan Infinite F50 plate reader with 40 
min incubation at 37°C and blank subtraction).
Impact of cell seeding density for ASC culture
Mechanically-isolated ASCs were seeded into 96-well cultures plates 
at various low densities from passages 2 to 5, in order to assess the lowest 
density for ASC culture and observe the evolution of population doubling 
time among the passages. Growth rates were assessed at day 12 according 
to a metabolic assay based on Cell Titer, as described above. Experiments 
were repeated three times with three different donors.
Differentiation culture assay and staining procedures
Differentiation assays were assessed to confirm that the 
differentiation potential is maintained with the retained protocols for 
mechanical mincing of small amounts of tissue, standard medium, 
low cell density seeding along with freezing of cell stocks. Cells from 
three patients were seeded at 3,000 cells/cm2 into 12-well plates and 
cultured with our standard culture medium (formulation A) for 3-5 
days, before the beginning of the differentiation assay, in order to 
obtain around 50% confluence. Cells were then cultured in 2ml of the 
proper induction medium and changed twice a week over a period 
of 21 days from the beginning of the induction (three experiments 
conducted in triplicate).
Osteogenic potential was induced with alpha-MEM, 10% FBS, 1% 
l-glut, 50μg/mL l-ascorbic acid, 5mM β-glycerophosphate and 100nM 
Table 1: Adipose tissue from healthy patients undergoing elective reconstructive 
surgeries
Id n° Gender Age BMI Technique
G01 F 49 24.2 lipoaspiration
G02 F 47 23 lipoaspiration
G03 F 47 30.1 direct excision
G04 F 51 26.4 lipoaspiration
G05 F 39 29.4 lipoaspiration
G06 F 27 24.5 lipoaspiration
G07 F 61 28.7 lipoaspiration
G08 F 45 21.3 direct excision
G09 F 46 24.2 direct excision
G010 F 49 22.3 lipoaspiration
G011 F 43 22.3 lipoaspiration
G012 F 52 28.7 direct excision
G013 F 41 26.3 direct excision
G014 F 54 21.9 direct excision
G015 F 40 27.7 direct excision
         
Figure 1: Processing of adipose tissue samples for primary culture
Adipose tissue was transported into the lab following tissue extraction (A) and 
following a first rinsing procedure in 5% P/S in PBS, adipose tissue was then 
minced into small pieces (<5mm) (B), rinsed again in 2% P/S (C) and resulting 
tissue pieces were placed into cell culture dishes that had been deeply scored 
with a scalpel to attach the tissue into the culture plate for primary culture (D). 
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dexamethasone. Adipogenic potential was induced with DMEM, 1% l-glut, 
1x ITS, 1μM dexamethasone, 100μM indomethacin and 100μM 3-isobutyl-1-
methylxanthine (IBMX). A part of osteogenically-induced cells in monolayer 
were fixed in 4% paraformaldehyde for 10 min at room temperature and 
washed with deionized H2O and followed standard von Kossa (VK), and 
Alizarin red (AR) staining procedures in order to show visual mineralization. 
The other cells were fixed in a citrate/acetone solution for 30 sec and followed 
alkaline phosphatase (ALP) staining to highlight ALP activity. Similarly, 
adipogenic-induced cells in monolayer were fixed in 4% paraformaldehyde 
and washed as described above and stained using Oil Red O (ORO) standard 
procedure to reveal cytoplasmic lipid deposits.
Cell stability and yield over passages using co-culture (FE-
002γ)
In order to assess potential growth stability and stimulation of ASC 
co-culture with progenitor fibroblasts, ASCs from 4 different patients were 
cultured between passages 4-6, with and without co-culture prepared with 
human progenitor skin cells (FE002-SK2) that had been gamma-irradiated 
with 200Gy (referred as FE002γ) (dose response was performed by using 
increment doses until no cell growth or colonies were formed). These off-
the-shelf frozen cell banks are used for routine skin graft cultures for severely 
burned patients in our hospital to provide cytokines and growth factors 
for better quality cell growth (Ethics protocol #62/07 and organ donation 
registered under the Federal Transplantation Program complying with the 
laws and Biobank procedures of the University Hospital of Lausanne and 
SwissMedic. The cells are registered with the European Collection of Cell 
Cultures with the Health Protection Agency at Porton Down, ECACC-FE-
002-SK2#12070301). These cells have been used in clinical trials as a viable 
fibroblast cell source for patients with burns and wounds [21,22]. Patient 
ASCs were seeded between 1,500-3,000 cells/cm2 into 75cm2 culture flasks 
with FE002γ at a constant dose of 1,000 cells/cm2. Cell growth of ASCs 
was assessed by trypan blue exclusion with total viable cell counts using a 
Neubauer growth chamber (hemocytometer) at 3-6 days. Control flasks 
of FE002γ alone were prepared for each experiment and did not show any 
cell growth or viability (trypan blue) following the irradiation and freezing 
protocol for preparation of clinical batches.
Biocompatibility assessment of biodegradable scaffold
Aiming for further clinical use on patients and better localized 
cell delivery, we evaluated the biocompatibility of the ASCs when 
seeded into a collagen membrane (TissuFleece E, Baxter). Briefly, 
cells were seeded at 1,000 cells/cm2 into the collagen matrix, and 
cellular colonisation of the matrix was evaluated by a Live/Dead 
metabolic assay at 3 different time points (24, 48, 72h in triplicate). 
The Live/Dead solution was prepared fresh [1ml PBS, 2µl Ethidium 
homodimer-1 (EthD-1), 0.5µl calcein acetsymethyl ester (calcein-
AM)] as described by the manufacturer (Life Technologies, L-3244, 
Live/Dead Viability/Cytotoxicity). Membranes were placed in 6-well 
culture plates, rinsed with PBS and 50µl of Live/Dead solution 
was pipetted onto each membrane.  They were incubated at room 
temperature for 30 min and images were taken with an Olympus IX81 
fluorescent microscope with an Andor iXon digital camera.
Results and Discussion
Standardization/simplification of isolation, expansion and 
stocking of adult ASCs
As regulations have been severely intensified for cell therapies, 
         
 
Figure 2: Media effect on ASC morphology and growth
Cell growth and morphology was compared using four different growth media. Resulting cell cultures plated at 3,000 cells/cm2 were imaged at 8 days and cell 
growth for 14 days was assessed with doubling times. Experiments were done in triplicate (mean ± SEM). Scale bar on images represents 100μm.
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each step including tissue procurement, cell isolation, cell culture and 
stocking is very important. Within the technical scope of manipulating 
stem cells for clinical use, procedures need to be simplified to assure 
safety and respect manufacturing guidelines. Using simple materials 
and methods for isolation is of utmost importance in order to treat the 
tissue and the subsequent cells in the least aggressive manner possible. 
In this study, the dissociation of small quantities of tissue could be 
done rapidly and without any aggressive enzymes, centrifugation 
forces or high serum treatments. Adipose tissue harvested from 15 
women patients was minced and placed into cell culture dishes (~1g) 
that had been scored to allow good attachment and early cell migration 
(Figure 1). Cells were seen to emerge as early as 3-4 days following this 
procedure and grown to confluence within 10-14 days (80-90% growth 
over culture surface) for all patients. By using this mechanical mincing 
and “direct attachment” procedure, only small amounts of tissue were 
necessary (Figure 1B,1D), which helped to avoid contamination since 
tissue could be dissected within small masses and not on the edges. 
Media optimization was then determined using three separate cell 
cultures and it was found that the most simple composition [DMEM 
/ FBS / l-glut (89:10:1)] was the most stable between passages. Early 
passage ASCs showed similar population doubling times with all 
media used (~110 h) (Figure 2). At later passages, the population 
doubling time was seen to increase in a linear manner with the DMEM 
/ FBS / l-glut (89:10:1), but the other media combinations portrayed 
high variability among passages. Once the culture conditions were 
determined, the use of collagenase treatment of various times (30 and 
120 min) was compared to the mechanical isolation procedure we 
have defined for tissue isolation. Since digestion is currently used for 
cell separation, it was of interest to see if this step could be eliminated 
and still have rapid cell growth. We found that 30 min of collagenase 
treatment showed lower cell growth compared to the less aggressive 
treatment of tissue without collagenase treatment. If tissue in small 
quantities (~10g) was subjected to 120 min of collagenase, there was 
no cell growth observed indicating that this variable may be of interest 
to eliminate. Other previous studies have shown that cell growth is 
sensitive to trypsin enzyme treatments also [15]. Freezing the cell 
gently with temperature increment freezing, and keeping them stored 
at only -80°C instead of liquid nitrogen (which is normally more 
difficult to have in the clinical surgical site) allowed very high viability 
(~97-98%) after 2 weeks or more. More important is the actual 
recovery of cultured ASCs following freezing protocols to assure 
their growth stability and potential to stock patient cells until they 
are needed for therapeutic procedures. With our isolation method, 
we have seen a slight shift in recovery of ASCs when cryo-preserved 
for two weeks or more by approximately 3 days, as compared to cells 
at the same passage without freezing (Figure 3). Even with a slight 
decrease in cell recovery once ASCs had been cryopreserved, banked 
cells would however allow to obtain high potential number of cells for 
patient treatments.
Maintenance of differentiation potential
The ASC culture with our defined protocol assured that patient 
cells maintained differentiation potential after 21 days of stimulation 
in respective media for osteogenic or adipogenic cell culture 
conditions (Figure 4). Osteogenic induction was observed by the 
presence of mineral deposition and enzymatic activity with three 
different staining procedures including Alizarin red (Figure 4A,4E), 
von Kossa (Figure 4B,4F) and alkaline phosphatase (Figure 4C,4G). 
There was light staining of ALP already in non-induced ASCs and 
since it has been shown that ALP enzymatic activity varies with the 
age of the donor, the two other staining procedures were used to 
evaluate mineralization. Adipogenic potential was seen by the large 
lipid droplets stained with oil red O in the induced cells (Figure 
4D,4H) and good overall differentiation potential was similar to that 
seen recently by Lin et al. [23] showing a uniform multipotent stem 
cell source.
Optimization of cell growth by seeding density and co-
culture
Low density seeding was accomplished over early passages 
(seeding densities of 325, 750, 1500 and 3000; passages 2-4) to observe 
full growth characteristics and all showed good cellular expansion 
capacity. The densities of 1500 to 3000 cells/cm2 would have a slight 
         
 
Figure 3: Recovery of ASCs following cryopreservation
Growth rate of cells after 2 weeks or more of cryopreservation ( ) were measured as a function of cell number over time in days. They were compared to cells 
at the same passages without cryopreservation ( ). Results are from experiments in triplicate (mean ± SEM).
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Figure 4: Osteogenic and adipogenic differentiation of ASCs
Patient ASCs were cultured in an osteogenic-inducing medium and stained with Alizarin red (A and E) and von Kossa (B and F) showing mineral deposits and 
alkaline phosphatase (C and G) showing enzymatic activity. ASCs were cultured in adipogenic-inducing medium and stained with oil red O showing lipid deposits 
(D and H). Scale bar on images represents 250µm.
         
 
Figure 5: Cell stability and yield over passages using co-culture (FE-002γ)
Cells from passage 6 of four patients are illustrated with growth conditions with and without skin progenitor cells (FE002γ, progenitor skin fibroblasts pre-treated 
with gamma irradiation of 200Gy and kept as frozen stocks) portraying typical fibroblastic cultures of later passages with many cells larger with wide cytoplasm 
when under normal culture conditions (without co-culture). ASCs grown in combination with FE002γ showed cell populations more similar to those in passage 
2-4 for most patients. Cell numbers were counted for each patient in triplicate without co-culture (dark grey) and with co-culture (light grey). Scale bar on images 
represents 100μm.
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benefit to obtain enough cells rapidly. Of the 15 patients, only two 
had cell growth that extended to passages 6 and beyond, without 
the typical cell morphology changes (enlarged cells with wide 
cytoplasmic spread). This aspect of culturing adult stem cells has 
also been illustrated by others showing slowing of cell growth and 
large, spreading cell morphology already at passage 4-6 [19]. Primary 
cell cultures from patient tissues are known to show heterogeneous 
growth capacities with overall lower growth over time. Because of 
this, we evaluated the use of co-culture directly with skin progenitor 
cells (FE002γ) to culture or to help adult adipocytes to remain stable 
over longer periods and thus, even higher passages could be used to 
prepare protocols for clinical batches of cells if needed. As early cells 
can only be frozen after several amplifications, it is only at passage 
2-3 that enough cells could be stocked. Therefore, placing the cells 
into culture with further expansion would bring them easily to 
passage 5-6. It would therefore be important, particularly for severely 
burned patients where multiple grafts are needed over time, to have 
the possibility to increase cell expansion potential for cells that may 
be relatively less stable over passages. This variability, when working 
with adult stem cells, has been difficult to integrate into standardized 
protocols. Cell growth of ASCs in the presence of FE002γ was found 
to be 40-50% higher in number and the morphology and stability 
         
 
Figure 6: Biocompatibility and delivery potential of ASCs in collagen scaffold
Cells were seeded into collagen scaffold (TissuFleece®, Baxter) and stained with Live/Dead kit after 24h (A) 48h (B) and 72h with live cells stained in green and 
rare non-viable cells in red. Scale bar on images represents 250μm.
         
 
Figure 7: Development of ASC banks and protocol to enhance cell stability through co-culture
Patient adipose tissue is micro-dissected into culture plates to allow rapid cell outgrowth and amplification for cryopreservation. Cells can be either used directly 
if enough cells are acquired or continued for expansion. Enhancement of cell numbers and quality can be obtained by co-culture with progenitor cells before 
associating them with matrix materials.
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were optimized (cells showing finer spindle-shaped morphology 
rather than large cytoplasm and large round cell morphology) (Figure 
5). Thus, we could increase total cell number through at least two cell 
passages. Use of FE002γ could prepare a robust adult ASC population 
for clinical use, as has been shown for skin cells for burn patients 
[21,22], and could be used in co-culture association for burn therapy. 
ASC association with delivery matrix for clinical application
By having more robust cells with the co-culture protocol, we have 
shown that these cells could be integrated easily with 3D scaffolds 
to provide a delivery system to the patient. Use of CE marked and 
clinical-grade hemostatic sponge collagens used routinely in surgery 
(TissuFleece E, Baxter) could be an elegant method to deliver 
ASCs now since they grow well in co-culture with fibroblasts. The 
ASCs showed integration into the matrix already at 24 h (Figure 
6A) and following 48 h adhered strongly and migrated within the 
scaffold (Figure 6B,6C). Patient ASCs could now be considered to be 
associated within biological bandages used for burn patients to help in 
overall skin repair and soft tissue reconstruction [21,22].
The recent study in the Lancet by Kole and colleagues [1] showed 
that fat grafts supplemented with autologous culture-expanded ASCs 
were able to increase graft volume retention up to ~81% compared to 
only ~16% if no cultured cells were associated to the human fat grafts 
transplanted into the upper arm [1]. Therefore, the specific technique 
for cultured ASCs has shown to be of importance for cell selection 
and activity. This technique could prove to be a great advantage for 
the future of lipofilling and soft tissue reconstruction. More and more 
patients are in need of lipofilling with delays between operations due 
to their pathologies (i.e. scleroderma or damage from radiotherapy). 
There are also situations where multiple injections are needed such 
as for breast augmentation or scar corrections. There are particular 
problems around implant surfaces and matrix enriched with stem 
cells could provide a solution to help integration into the surrounding 
tissues with improved tolerance.
Importantly, ASCs could be added to grafting procedures 
routinely used for severely burned patients adding them with co-
culture of keratinocytes and fibroblasts. Thus, having stocks of cells 
from individual patients would be of benefit for a large variety of 
interventions. The lower amounts of fat tissue from donor sites would 
increase safety and minimize donor site deformation. Furthermore, it 
would be possible to obtain sufficient amount of cultured ASCs also 
from patients with low fat deposit and for severely burned patients 
and their use could be a great advantage to be associated with fat grafts 
or skin grafts.
Methods and techniques for cellular therapies have to be performed 
under full Good Manufacturing Processes (cGMP compliance). As 
all the techniques for burn management use traditional methods 
employing basic media, fetal bovine serum and growth factors since 
30 years in our hospital, it is of importance to include this new cell 
type with similar adapted culture conditions as has been positively 
illustrated in this study and adapt in a step-wise manner for potential 
improvements.
To this end, there has been much effort world-wide imagining 
the replacment of animal components in tissue and cell processing 
including patient serum [19], platelet derivatives [5,24,25] and 
recombinant growth factors [26,27]. These alternatives could now 
be analyzed in our long-term clinical setting to see if cellular growth 
and stability of cell stocks can be maintained whenever instigating 
changes in clinical protocols. All of these should be done step-by-step 
to assure the high quality necessary for patient use.
Conclusions
When working with tissue and stem cell isolation procedures 
that are destined for clinical use, it is important to have the simplest 
and the least aggressive treatments to allow robust cell populations. 
With mechanical isolation of ASCs instead of more common (but 
also more aggressive) enzymatic treatments, it is possible to obtain 
better cell growth alongside full maintenance of the differentiation 
potential. The cells could be frozen with a high survival rate (~98%) 
up to passages 4-6 and then co-cultured with FE002γ to improve the 
stability. Co-culture can significantly enhance primary ASC culture 
with higher numbers of patient cells obtained from a low quantity 
of tissue so that it would be possible to store the cells and thaw 
them when needed for transplantation. Finally, the fact that ASCs 
could be dispersed on collagen scaffolds with a good survival opens 
the possibility to use them in various manners, including filling of 
larger gaps and for skin grafting techniques routinely used to allow 
better soft tissue reconstruction with co-culture of keratinocytes and 
fibroblasts for burn patients (Figure 7). Cell culture assisted surgical 
techniques will need to be developed with Good Manufacturing 
Processing in mind since regulations have become more strict in the 
hospital environment, but taking care at integrating each cell type 
at each step of the tissue processing will increase benefits towards 
patient treatments and safety.
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